Royal Bank Of Canada Dice Therapeutics, Inc. Transaction History

Royal Bank Of Canada

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	BUY	$25.86 - $46.71 $18,179 - $32,837	703 Added 35.29%	2,695 $125,000
Q1 2023 May 15, 2023	SELL	$26.05 - $32.31 $67,209 - $83,359	-2,580 Reduced 56.43%	1,992 $57,000
Q4 2022 Feb 14, 2023	BUY	$19.77 - $42.23 $83,548 - $178,463	4,226 Added 1221.39%	4,572 $142,000
Q3 2022 Nov 14, 2022	BUY	$14.97 - $22.65 $2,784 - $4,212	186 Added 116.25%	346 $7,000
Q2 2022 Aug 15, 2022	SELL	$13.19 - $22.1 $9,180 - $15,381	-696 Reduced 81.31%	160 $2,000
Q1 2022 May 16, 2022	SELL	$14.54 - $25.02 $28,963 - $49,839	-1,992 Reduced 69.94%	856 $16,000
Q4 2021 Feb 14, 2022	BUY	$22.41 - $37.54 $63,823 - $106,913	2,848 New	2,848 $72,000

17.7K

13K

Ticker DICE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 46,430,000
Description
DICE Therapeutics, Inc., a biopharmaceutical company, builds various oral therapeutic candidates to treat chronic diseases in immunology and other therapeutic areas. Its platform DELSCAPE, is designed to discover selective oral small molecules to modulate protein-protein interactions (PPIs) as effectively as systemic biologics. The company's lea...

Get notified when there are updates to the investment portfolio of Royal Bank Of Canada, based on Form 13F filings with the SEC.

Stay updated on Royal Bank Of Canada with notifications on news.